Recently,the use of endovascular denervation(EDN)to treat resistant hypertension has gained significant attention.In addition to reducing sympathetic activity,EDN might also have beneficial effects on pulmonary arteri...Recently,the use of endovascular denervation(EDN)to treat resistant hypertension has gained significant attention.In addition to reducing sympathetic activity,EDN might also have beneficial effects on pulmonary arterial hypertension,insulin resistance,chronic kidney disease,atrial fibrillation,heart failure,obstructive sleep apnea syndrome,loin pain hematuria syndrome,cancer pain and so on.In this article we will summarize the progress of EDN in clinical research.展开更多
基金by the Program for Integrated Traditional Chinese and Western Medicine in Shandong Province of China(YXH2019ZXY007)Ji’nan Professionals Development Special Fund(20228118)+1 种基金Science and Technology Project of(Sinopec Group)Shengli Petroleum Administration Co.,Ltd(GKY2001)Science and Technology Project of Ji'nan Health Committee(2020-3-65).
基金supported by the National Natural Science Foundation of China General Project(81971716)Jiangsu Science Foundation of China Youth Project(BK20200365)。
文摘Recently,the use of endovascular denervation(EDN)to treat resistant hypertension has gained significant attention.In addition to reducing sympathetic activity,EDN might also have beneficial effects on pulmonary arterial hypertension,insulin resistance,chronic kidney disease,atrial fibrillation,heart failure,obstructive sleep apnea syndrome,loin pain hematuria syndrome,cancer pain and so on.In this article we will summarize the progress of EDN in clinical research.
